Works by Zijlstra, Josee


Results: 105
    1
    2
    3

    Non-specific irreversible <sup>89</sup>Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using <sup>89</sup>Zr-immuno-PET.

    Published in:
    EJNMMI Research, 2024, v. 14, p. 1, doi. 10.1186/s13550-024-01079-5
    By:
    • Wijngaarden, Jessica E.;
    • Jauw, Yvonne W. S.;
    • Zwezerijnen, Gerben J. C.;
    • de Wit-van der Veen, Berlinda J.;
    • Vugts, Daniëlle J.;
    • Zijlstra, Josée M.;
    • van Dongen, Guus A. M. S.;
    • Boellaard, Ronald;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Huisman, Marc C.
    Publication type:
    Article
    4
    5
    6
    7
    8

    Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma.

    Published in:
    Cancers, 2022, v. 14, n. 5, p. 1346, doi. 10.3390/cancers14051346
    By:
    • Plaça, Jessica Rodrigues;
    • Diepstra, Arjan;
    • Los, Tjitske;
    • Mendeville, Matías;
    • Seitz, Annika;
    • Lugtenburg, Pieternella J.;
    • Zijlstra, Josée;
    • Lam, King;
    • da Silva Jr., Wilson Araújo;
    • Ylstra, Bauke;
    • de Jong, Daphne;
    • van den Berg, Anke;
    • Nijland, Marcel
    Publication type:
    Article
    9

    Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors: Results of a Randomized Controlled Trial.

    Published in:
    Cancers, 2021, v. 13, n. 19, p. 4948, doi. 10.3390/cancers13194948
    By:
    • Starreveld, Daniëlle E. J.;
    • Daniels, Laurien A.;
    • Kieffer, Jacobien M.;
    • Valdimarsdottir, Heiddis B.;
    • de Geus, Jessie;
    • Lanfermeijer, Mirthe;
    • van Someren, Eus J. W.;
    • Habers, G. Esther A.;
    • Bosch, Jos A.;
    • Janus, Cécile P. M.;
    • van Spronsen, Dick Johan;
    • de Weijer, Roel J.;
    • Marijt, Erik W. A.;
    • de Jongh, Eva;
    • Zijlstra, Josée M.;
    • Böhmer, Lara H.;
    • Houmes, Margreet;
    • Kersten, Marie José;
    • Korse, Catharina M.;
    • van Rossum, Huub H.
    Publication type:
    Article
    10
    11

    R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00723-4
    By:
    • Al-Sarayfi, Diana;
    • Meeuwes, Frederik O.;
    • Durmaz, Müjde;
    • Issa, Djamila E.;
    • Brouwer, Rolf E.;
    • Beeker, Aart;
    • van Rhenen, Anna;
    • Mutsaers, Pim G. N. J.;
    • Böhmer, Lara H.;
    • van der Poel, Marjolein W. M.;
    • te Boome, Liane;
    • van Meerten, Tom;
    • Chamuleau, Martine E. D.;
    • Zijlstra, Josée M.;
    • Brink, Mirian;
    • Nijland, Marcel
    Publication type:
    Article
    12

    Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989–2018.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00637-1
    By:
    • Durmaz, Müjde;
    • Visser, Otto;
    • Posthuma, Eduardus F. M.;
    • Brouwer, Rolf E.;
    • Issa, Djamila E.;
    • de Jong, Daphne;
    • Lam, King H.;
    • Blijlevens, Nicole M. A.;
    • Zijlstra, Josée M.;
    • Chamuleau, Martine E. D.;
    • Lugtenburg, Pieternella J.;
    • Kersten, Marie José;
    • Dinmohamed, Avinash G.
    Publication type:
    Article
    13
    14

    Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 4, p. 724, doi. 10.1093/neuonc/noad224
    By:
    • Bromberg, Jacoline E C;
    • Issa, Samar;
    • van der Holt, Bronno;
    • van der Meulen, Matthijs;
    • Dirven, Linda;
    • Minnema, Monique C;
    • Seute, Tatjana;
    • Durian, Marc;
    • Cull, Gavin;
    • Poel, Marjolein W M van der;
    • Stevens, Wendy B C;
    • Zijlstra, Josee M;
    • Brandsma, Dieta;
    • Nijland, Marcel;
    • Mason, Kylie D;
    • Beeker, Aart;
    • Abrahamse-Testroote, Martine C J;
    • Bent, Martin J van den;
    • Jong, Daphne de;
    • Doorduijn, Jeanette K
    Publication type:
    Article
    15
    16
    17

    Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 483, doi. 10.1016/j.clml.2021.12.016
    By:
    • Schuster, Michael;
    • Zijlstra, Josée;
    • Casasnovas, Rene-Olivier;
    • Vermaat, Joost S. P.;
    • Kalakonda, Nagesh;
    • Goy, Andre;
    • Choquet, Sylvain;
    • Neste, Eric Van Den;
    • Hill, Brian;
    • Thieblemont, Catherine;
    • Cavallo, Federica;
    • Cruz, Fatima De la;
    • Kuruvilla, John;
    • Hamad, Nad;
    • Jaeger, Ulrich;
    • Caimi, Paolo;
    • Gurion, Ronit;
    • Warzocha, Krzysztof;
    • Bakhshi, Sameer;
    • Sancho, Juan-Manuel
    Publication type:
    Article
    18

    Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 24, doi. 10.1016/j.clml.2021.07.017
    By:
    • Casasnovas, Rene-Olivier;
    • Follows, George;
    • Zijlstra, Josee M.;
    • Vermaat, Joost S.P.;
    • Kalakonda, Nagesh;
    • Choquet, Sylvain;
    • Van Den Neste, Eric;
    • Hill, Brian;
    • Thieblemont, Catherine;
    • Cavallo, Federica;
    • De la Cruz, Fatima;
    • Kuruvilla, John;
    • Hamad, Nada;
    • Jaeger, Ulrich;
    • Caimi, Paolo F.;
    • Gurion, Ronit;
    • Warzocha, Krzysztof;
    • Bakhshi, Sameer;
    • Sancho, Juan-Manuel;
    • Schuster, Michael
    Publication type:
    Article
    19

    A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S248, doi. 10.1016/j.clml.2019.07.153
    By:
    • Kalakonda, Nagesh;
    • Cavallo, Federica;
    • Follows, George;
    • Goy, Andre;
    • Vermaat, Joost S.P.;
    • Casasnovas, Olivier;
    • Lavee, Orly;
    • Maerevoet, Marie;
    • Zijlstra, Josée;
    • Bakhshi, Sameer;
    • Bouabdallah, Reda;
    • Choquet, Sylvain;
    • Gurion, Ronit;
    • Hill, Brian;
    • Jaeger, Ulrich;
    • Sancho, Juan-Manuel;
    • Schuster, Michael;
    • Thieblemont, Catherine;
    • De la Cruz, Fatima;
    • Egyed, Miklós
    Publication type:
    Article
    20

    Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.

    Published in:
    2021
    By:
    • Maerevoet, Marie;
    • Zijlstra, Josee M.;
    • Follows, George;
    • Casasnovas, Rene-Olivier;
    • Vermaat, J. S. P.;
    • Kalakonda, Nagesh;
    • Goy, Andre;
    • Choquet, Sylvain;
    • Van Den Neste, Eric;
    • Hill, Brian;
    • Thieblemont, Catherine;
    • Cavallo, Federica;
    • De la Cruz, Fatima;
    • Kuruvilla, John;
    • Hamad, Nada;
    • Jaeger, Ulrich;
    • Caimi, Paolo;
    • Gurion, Ronit;
    • Warzocha, Krzysztof;
    • Bakhshi, Sameer
    Publication type:
    Letter
    21
    22

    Cost-Utility of the eHealth Application 'Oncokompas', Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial.

    Published in:
    Current Oncology, 2022, v. 29, n. 9, p. 6186, doi. 10.3390/curroncol29090486
    By:
    • Schuit, Anouk S.;
    • Holtmaat, Karen;
    • Coupé, Veerle M. H.;
    • Eerenstein, Simone E. J.;
    • Zijlstra, Josée M.;
    • Eeltink, Corien;
    • Becker-Commissaris, Annemarie;
    • van Zuylen, Lia;
    • van Linde, Myra E.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Sommeijer, Dirkje W.;
    • Verbeek, Nol;
    • Bosscha, Koop;
    • Nandoe Tewarie, Rishi;
    • Sedee, Robert-Jan;
    • de Bree, Remco;
    • de Graeff, Alexander;
    • de Vos, Filip;
    • Cuijpers, Pim;
    • Verdonck-de Leeuw, Irma M.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1315, doi. 10.1093/neuonc/noab021
    By:
    • van der Meulen, Matthijs;
    • Dirven, Linda;
    • Habets, Esther J J;
    • Bakunina, Katerina;
    • Smits, Marion;
    • Achterberg, Hakim C;
    • Seute, Tatjana;
    • Cull, Gavin;
    • Schouten, Harry;
    • Zijlstra, Josée M;
    • Brandsma, Dieta;
    • Enting, Roelien H;
    • Beijert, Max;
    • Taphoorn, Martin J B;
    • Bent, Martin J van den;
    • Issa, Samar;
    • Doorduijn, Jeanette K;
    • Bromberg, Jacoline E C
    Publication type:
    Article
    29
    30

    Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 24, p. 4285, doi. 10.1002/cncr.34464
    By:
    • Krul, Inge M.;
    • Boekel, Naomi B.;
    • Kramer, Iris;
    • Janus, Cécile P. M.;
    • Krol, Augustinus D. G.;
    • Nijziel, Marten R.;
    • Zijlstra, Josée M.;
    • van der Maazen, Richard W. M.;
    • Roesink, Judith M.;
    • Jacobse, Judy N.;
    • Schaapveld, Michael;
    • Schmidt, Marjanka K.;
    • Opstal‐van Winden, Annemieke W. J.;
    • Sonke, Gabe S.;
    • Russell, Nicola S.;
    • Aleman, Berthe M. P.;
    • van Leeuwen, Flora E.
    Publication type:
    Article
    31
    32
    33

    Overall and disease‐specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 1, p. 190, doi. 10.1002/cam4.1922
    By:
    • Rigter, Lisanne S.;
    • Schaapveld, Michael;
    • Janus, Cecile P. M.;
    • Krol, Augustinus D. G.;
    • Maazen, Richard W. M.;
    • Roesink, Judith;
    • Zijlstra, Josee M.;
    • Imhoff, Gustaaf W.;
    • Poortmans, Philip M. P.;
    • Beijert, Max;
    • Lugtenburg, Pieternella J.;
    • Visser, Otto;
    • Snaebjornsson, Petur;
    • Eggermond, Anna M.;
    • Aleman, Berthe M. P.;
    • Leeuwen, Flora E.;
    • Leerdam, Monique E.
    Publication type:
    Article
    34

    <sup>89</sup>Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224568
    By:
    • Jauw, Yvonne W. S.;
    • O’Donoghue, Joseph A.;
    • Zijlstra, Josée M.;
    • Hoekstra, Otto S.;
    • Willemien Menke-van der Houven van Oordt, C.;
    • Morschhauser, Franck;
    • Carrasquillo, Jorge A.;
    • Zweegman, Sonja;
    • Taskar, Neeta Pandit-;
    • Lammertsma, Adriaan A.;
    • van Dongen, Guus. A. M. S.;
    • Boellaard, Ronald;
    • Weber, Wolfgang A.;
    • Huisman, Marc C.
    Publication type:
    Article
    35
    36
    37
    38
    39

    Bortezomib maintenance after R‐CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial.

    Published in:
    British Journal of Haematology, 2020, v. 190, n. 3, p. 385, doi. 10.1111/bjh.16567
    By:
    • Doorduijn, Jeanette K.;
    • Zijlstra, Josee M.;
    • Lugtenburg, Pieternella J.;
    • Kersten, Marie Josee;
    • Böhmer, Lara H.;
    • Minnema, Monique C.;
    • MacKenzie, Marius A.;
    • van Marwijk Kooij, Rien;
    • Jongh, Eva;
    • Snijders, Tjeerd J.F.;
    • Weerdt, Okke;
    • Gelder, Michel;
    • Hoogendoorn, Mels;
    • Leys, Rineke B.L.;
    • Kibbelaar, Robby E.;
    • Jong, Daphne;
    • Chitu, Dana A.;
    • Van't Veer, Mars B.;
    • Kluin‐Nelemans, Hanneke C.
    Publication type:
    Article
    40

    Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population‐based study during 1990–2015.

    Published in:
    British Journal of Haematology, 2020, v. 189, n. 6, p. 1093, doi. 10.1111/bjh.16491
    By:
    • Reedijk, Ardine M. J.;
    • Zijtregtop, Eline A. M.;
    • Coebergh, Jan Willem W.;
    • Meyer‐Wentrup, Friederike A. G.;
    • Hebeda, Konnie M.;
    • Zwaan, C. Michel;
    • Janssens, Geert O. R.;
    • Pieters, Rob;
    • Plattel, Wouter J.;
    • Dinmohamed, Avinash G.;
    • Zijlstra, Josée M.;
    • Kremer, Leontien C. M.;
    • Lugtenburg, Pieternella J.;
    • Beishuizen, Auke;
    • Karim‐Kos, Henrike E.
    Publication type:
    Article
    41
    42

    Rituximab‐PECC induction followed by <sup>90</sup>Y‐ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 3, p. 347, doi. 10.1111/bjh.16087
    By:
    • Lugtenburg, Pieternella J.;
    • Zijlstra, Josee M.;
    • Doorduijn, Jeanette K.;
    • Böhmer, Lara H.;
    • Hoogendoorn, Mels;
    • Berenschot, Henriette W.;
    • Beeker, Aart;
    • van der Burg‐de Graauw, Nicole C.;
    • Schouten, Harry C.;
    • Bilgin, Yavuz M.;
    • Kersten, Marie‐Jose;
    • Koene, Harry R.;
    • Herbers, Alexandra H. E.;
    • de Jong, Daphne;
    • Hijmering, Nathalie;
    • Lam, King H.;
    • Chiţu, Dana;
    • Brouwer, Rolf E.;
    • van Imhoff, Gustaaf W.
    Publication type:
    Article
    43

    Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma.

    Published in:
    British Journal of Haematology, 2019, v. 186, n. 4, p. e103, doi. 10.1111/bjh.15936
    By:
    • Nijdam, Annelies;
    • Dekker, Nicky;
    • Aleman, Berthe M. P.;
    • van 't Veer, Mars B.;
    • Daniels, Laurien A.;
    • Maazen, Richard W.;
    • Janus, Cecile P. M.;
    • Weijer, Roel J.;
    • Zijlstra, Josée M.;
    • Stedema, Floriske G.;
    • Ta, Bastiaan D.;
    • Posthuma, Eduardus F. M.;
    • Manenschijn, Annelies;
    • Dielwart, Michel F. H.;
    • Bilgin, Yavuz M.;
    • Heuvel, Maaike J.;
    • Boersma, Rinske S.;
    • Leeuwen, Flora E.;
    • Raemaekers, John M. M.
    Publication type:
    Article
    44

    Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 1, p. 50, doi. 10.1111/bjh.12346
    By:
    • Regelink, Josien C.;
    • Minnema, Monique C.;
    • Terpos, Evangelos;
    • Kamphuis, Marjolein H.;
    • Raijmakers, Pieter G.;
    • Pieters – van den Bos, Indra C.;
    • Heggelman, Ben G. F.;
    • Nievelstein, Rutger‐Jan;
    • Otten, Rene. H. J.;
    • Lammeren – Venema, Danielle;
    • Zijlstra, Josee M.;
    • Arens, Anne I. J.;
    • Rooy, Jacky W.;
    • Hoekstra, Otto S.;
    • Raymakers, Reinier;
    • Sonneveld, Pieter;
    • Ostelo, Raymond W.;
    • Zweegman, Sonja
    Publication type:
    Article
    45
    46

    Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 2, p. 486, doi. 10.1007/s00259-022-05977-5
    By:
    • Zwezerijnen, Gerben J. C.;
    • Eertink, Jakoba J.;
    • Ferrández, Maria C.;
    • Wiegers, Sanne E.;
    • Burggraaff, Coreline N.;
    • Lugtenburg, Pieternella J.;
    • Heymans, Martijn W.;
    • de Vet, Henrica C. W.;
    • Zijlstra, Josée M.;
    • Boellaard, Ronald
    Publication type:
    Article
    47

    Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4642, doi. 10.1007/s00259-022-05916-4
    By:
    • Eertink, Jakoba J.;
    • Zwezerijnen, Gerben J. C.;
    • Cysouw, Matthijs C. F.;
    • Wiegers, Sanne E.;
    • Pfaehler, Elisabeth A. G.;
    • Lugtenburg, Pieternella J.;
    • van der Holt, Bronno;
    • Hoekstra, Otto S.;
    • de Vet, Henrica C. W.;
    • Zijlstra, Josée M.;
    • Boellaard, Ronald
    Publication type:
    Article
    48

    <sup>18</sup>F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 3, p. 932, doi. 10.1007/s00259-021-05480-3
    By:
    • Eertink, Jakoba J.;
    • van de Brug, Tim;
    • Wiegers, Sanne E.;
    • Zwezerijnen, Gerben J. C.;
    • Pfaehler, Elisabeth A. G.;
    • Lugtenburg, Pieternella J.;
    • van der Holt, Bronno;
    • de Vet, Henrica C. W.;
    • Hoekstra, Otto S.;
    • Boellaard, Ronald;
    • Zijlstra, Josée M.
    Publication type:
    Article
    49

    Interobserver reproducibility of tumor uptake quantification with <sup>89</sup>Zr-immuno-PET: a multicenter analysis.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1840, doi. 10.1007/s00259-019-04377-6
    By:
    • Jauw, Yvonne W. S.;
    • Bensch, Frederike;
    • Brouwers, Adrienne H.;
    • Hoekstra, Otto S.;
    • Zijlstra, Josée M.;
    • Pieplenbosch, Simone;
    • Schröder, Carolien P.;
    • Zweegman, Sonja;
    • van Dongen, Guus A. M. S.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • de Vries, Elisabeth G. E.;
    • de Vet, Henrica C. W.;
    • Boellaard, Ronald;
    • Huisman, Marc C.
    Publication type:
    Article
    50